Literature DB >> 2971871

Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.

S H Berger1, F G Berger.   

Abstract

A panel of seven human colorectal cell lines of differing phenotype has been examined to elucidate the role of thymidylate synthase (TS) in the response to 5-fluoro-2'-deoxyuridine (FdUrd). Although TS is a major target of FdUrd, no consistent relationship was observed between the intracellular levels of TS and the response to FdUrd among the cell lines. Levels of thymidine kinase and dihydrofolate reductase, enzymes that are involved in generation of ligands that form the inhibitory ternary complex with TS, do not correlate with FdUrd response. Two cell lines that exhibit innate resistance to FdUrd, relative to the other cell lines, have variations in TS enzyme structure or gene structure. Cell line HCT 116 contains two forms of TS, as defined by isoelectric focusing. One form, which is unique to HCT 116, is more basic than the common form, which is present in all the cell lines. Cell line RCA contains a variation in the TS structural gene, as defined by restriction fragment-length analysis. These structural variations, which are associated with reduced response to FdUrd, may serve as markers for reduced clinical response to TS-directed chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971871

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase.

Authors:  Maria Marjorette O Peña; Yang Yang Xing; Sangita Koli; Franklin G Berger
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

2.  Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-Fluorouracil drug response.

Authors:  A Calascibetta; Flavia Contino; S Feo; G Gulotta; M Cajozzo; A Antona; G Sanguedolce; R Sanguedolce
Journal:  J Nucleic Acids       Date:  2010-01-26

3.  Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines.

Authors:  Kazuya Uchibori; Atsushi Kasamatsu; Masahiko Sunaga; Satoshi Yokota; Tomoya Sakurada; Eriko Kobayashi; Masaharu Yoshikawa; Katsuhiro Uzawa; Shiro Ueda; Hideki Tanzawa; Nobunori Sato
Journal:  Int J Oncol       Date:  2011-12-15       Impact factor: 5.650

4.  The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines.

Authors:  E J Estlin; K Balmanno; A H Calvert; A G Hall; J Lunec; D R Newell; A D Pearson; G A Taylor
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells.

Authors:  Yoshihiro Matsumoto; Victoria Rodriguez; Tracy A Whitford; Neil Beeharry; Hiroshi Ide; Alan E Tomkinson
Journal:  Oncoscience       Date:  2015-02-09

6.  Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.

Authors:  Fabian Dominik Mairinger; Claudia Vollbrecht; Elena Flom; Daniel Christian Christoph; Kurt-Werner Schmid; Jens Kollmeier; Helmut Hans Popper; Thomas Mairinger; Robert Fred Henry Walter
Journal:  Oncotarget       Date:  2017-06-06

7.  Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.

Authors:  M Inaba; J Mitsuhashi; H Sawada; N Miike; Y Naoe; A Daimon; K Koizumi; H Tsujimoto; M Fukushima
Journal:  Jpn J Cancer Res       Date:  1996-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.